Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19

Asad J Torabi1, Josue Villegas-Galaviz2, Maya Guglin1

  • 1Division of Cardiology, Krannert Institute of Cardiology at Indiana University School of Medicine, 1800 N Capital Avenue, Indianapolis, IN 46202, USA.

Future Cardiology
|October 20, 2020
PubMed

Insights

A young COVID-19 patient developed severe Takotsubo cardiomyopathy and cardiogenic shock following cardiac tamponade. This case highlights the critical cardiovascular complications associated with coronavirus disease 2019.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Takotsubo cardiomyopathy, or stress-induced cardiomyopathy, is a recognized cause of heart failure.
  • Cardiovascular complications are increasingly reported in patients with coronavirus disease 2019 (COVID-19).

Observation:

  • A 42-year-old woman with COVID-19 presented with fever, altered mental status, and hypoxia.
  • She was diagnosed with cardiac tamponade and underwent pericardiocentesis.
  • Within two hours, she developed Takotsubo cardiomyopathy and cardiogenic shock.

Findings:

  • This case presents a rare and severe manifestation of Takotsubo cardiomyopathy in a young COVID-19 patient.
  • The rapid progression from cardiac tamponade to cardiogenic shock was a notable feature.
  • The patient's condition rapidly deteriorated, leading to death on the same day.

Implications:

  • Clinicians must be aware of the diverse and severe cardiovascular complications of COVID-19.
  • Early recognition and management of cardiac events in COVID-19 patients are crucial.
  • This case underscores the potential for Takotsubo cardiomyopathy as a critical complication of severe COVID-19 infection.

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
187
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
266
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
93
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
156